Literature DB >> 25145701

Monitoring of chimerism following allogeneic haematopoietic stem cell transplantation (HSCT): technical recommendations for the use of short tandem repeat (STR) based techniques, on behalf of the United Kingdom National External Quality Assessment Service for Leucocyte Immunophenotyping Chimerism Working Group.

Jordan R Clark1, Stuart D Scott, Andrea L Jack, Helena Lee, Joanne Mason, Geoffrey I Carter, Laurence Pearce, Tony Jackson, Hazel Clouston, Anne Sproul, Leigh Keen, Karen Molloy, Najeem'deen Folarin, Liam Whitby, John A Snowden, John T Reilly, David Barnett.   

Abstract

Analysis of short tandem repeats (STR) is the predominant method for post-transplant monitoring of donor engraftment. It can enable early detection of disease relapse, level of engraftment and provide useful information on the graft-versus-host disease (GVHD)/graft-versus-tumour (GVT) effect, facilitating therapeutic intervention. Harmonization and standardization of techniques and result interpretation is essential to reduce the impact of laboratory variability on both clinical management and the results of multi-centre clinical trials. However, the United Kingdom National External Quality Assessment Service for Leucocyte Immunophenotyping (UK NEQAS LI) has highlighted significant issues inherent in STR testing that impact upon inter- and intra- laboratory variation. We present here consensus best practice guidelines and recommendations for STR chimerism testing, data interpretation and reporting that have been drawn up and agreed by a consortium of 11 UK and Eire clinical laboratories. This document uses data obtained from the UK NEQAS LI Post-Stem Cell Transplant (SCT) Chimerism Monitoring Programme.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  allogeneic haematopoietic stem cell transplantation; chimerism; guidelines; short tandem repeats

Mesh:

Year:  2014        PMID: 25145701     DOI: 10.1111/bjh.13073

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  28 in total

1.  Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation.

Authors:  Susan Prockop; Ekaterina Doubrovina; Stephanie Suser; Glenn Heller; Juliet Barker; Parastoo Dahi; Miguel A Perales; Esperanza Papadopoulos; Craig Sauter; Hugo Castro-Malaspina; Farid Boulad; Kevin J Curran; Sergio Giralt; Boglarka Gyurkocza; Katharine C Hsu; Ann Jakubowski; Alan M Hanash; Nancy A Kernan; Rachel Kobos; Guenther Koehne; Heather Landau; Doris Ponce; Barbara Spitzer; James W Young; Gerald Behr; Mark Dunphy; Sofia Haque; Julie Teruya-Feldstein; Maria Arcila; Christine Moung; Susan Hsu; Aisha Hasan; Richard J O'Reilly
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

2.  Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial.

Authors:  Jessica M Fogel; Sarah E Hudelson; San-San Ou; Stephen Hart; Carole Wallis; Mariza G Morgado; Shanmugam Saravanan; Srikanth Tripathy; Laura Hovind; Estelle Piwowar-Manning; Devin Sabin; Marybeth McCauley; Theresa Gamble; Xinyi C Zhang; Joseph J Eron; Joel E Gallant; Johnstone Kumwenda; Joseph Makhema; Nagalingeswaran Kumarasamy; Suwat Chariyalertsak; James Hakim; Sharlaa Badal-Faesen; Victor Akelo; Mina C Hosseinipour; Breno R Santos; Sheela V Godbole; Jose H Pilotto; Beatriz Grinsztejn; Ravindre Panchia; Kenneth H Mayer; Ying Q Chen; Myron S Cohen; Susan H Eshleman
Journal:  J Acquir Immune Defic Syndr       Date:  2016-07-01       Impact factor: 3.731

3.  Obstructive sleep apnea and craniofacial appearance in MPS type I-Hurler children after hematopoietic stem cell transplantation.

Authors:  Till Koehne; Sarah Müller-Stöver; Anja Köhn; Katharina Stumpfe; Susanne Lezius; Carmen Schmid; Zoltan Lukacs; Bärbel Kahl-Nieke; Nicole Muschol
Journal:  Sleep Breath       Date:  2019-07-22       Impact factor: 2.816

4.  The clinical application of SNP-based next-generation sequencing (SNP-NGS) for evaluation of chimerism and microchimerism after HLA-mismatched stem cell microtransplantation.

Authors:  Weiyang Li; Yi Xu; Yufeng Feng; Haixia Zhou; Xiao Ma; Depei Wu; Suning Chen; Aining Sun
Journal:  Int J Hematol       Date:  2022-07-08       Impact factor: 2.319

5.  Maternal T-Cell Engraftment Interferes With Human Leukocyte Antigen Typing in Severe Combined Immunodeficiency.

Authors:  Chang Liu; Brian Duffy; Jeffrey J Bednarski; Cecelia Calhoun; Lindsay Lay; Barrett Rundblad; Jacqueline E Payton; Thalachallour Mohanakumar
Journal:  Am J Clin Pathol       Date:  2016-02-01       Impact factor: 2.493

6.  Influence of Mixed Chimerism on Outcome in Children With Anaemia After Haematopoietic Stem Cell Transplantation.

Authors:  Monika Lejman; Joanna Zawitkowska; Agnieszka Zaucha-Prażmo; Magdalena Cienkusz; Aleksandra Mroczkowska; Jerzy Kowalczyk; Katarzyna Drabko
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

7.  Intensive monitoring of minimal residual disease and chimerism after allogeneic hematopoietic stem cell transplantation for acute leukemia in children.

Authors:  Thomas Pincez; Raoul Santiago; Michel Duval; Sonia Cellot; Henrique Bittencourt; Isabelle Louis; Mélanie Bilodeau; Alexandre Rouette; Loubna Jouan; Josette-Renée Landry; Françoise Couture; Johanne Richer; Pierre Teira
Journal:  Bone Marrow Transplant       Date:  2021-09-02       Impact factor: 5.483

8.  Donor-Host Lineage-Specific Chimerism Monitoring and Analysis in Pediatric Patients Following Allogeneic Stem Cell Transplantation: Influence of Pretransplantation Variables and Correlation with Post-Transplantation Outcomes.

Authors:  Gabriela Llaurador; Eileen Nicoletti; Susan E Prockop; Susan Hsu; Kirsten Fuller; Audrey Mauguen; Richard J O'Reilly; Jaap J Boelens; Farid Boulad
Journal:  Transplant Cell Ther       Date:  2021-05-31

Review 9.  Pooling biomarker data from different studies of disease risk, with a focus on endogenous hormones.

Authors:  Timothy J Key; Paul N Appleby; Naomi E Allen; Gillian K Reeves
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-16       Impact factor: 4.254

10.  Predicting the prevalence of chronic kidney disease in the English population: a cross-sectional study.

Authors:  Benjamin Kearns; Hugh Gallagher; Simon de Lusignan
Journal:  BMC Nephrol       Date:  2013-02-25       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.